DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Actimmune (Interferon Gamma-1B) - Current Clinical Trials

 
 



Actimmune Related Clinical Trials

Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis [Completed]

A Phase II Study to Determine the Safety and Efficacy of Interferon-Gamma in Patients With Chronic Hepatitis B [Not yet recruiting]

A Pilot Study of Aerosol Interferon-Gamma for Treatment of Idiopathic Pulmonary Fibrosis [Recruiting]

Topical Interferon Gamma for Macular Edema Caused by Uveitis [Recruiting]

The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) [Terminated]

Topical Interferon Gamma-1b for Central Serous Chorioretinopathy [Recruiting]

An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF [Terminated]

Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer [Terminated]

Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia [Recruiting]

Phase I/II Study of Recombinant Human Interferon-Gamma (rIFN-Gamma) in HIV-Infected Children [Completed]

Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis [Completed]

Interferon-Gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-Responders [Recruiting]

Interferon Gamma for Drug Resistant Tuberculosis [Completed]

Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I [Completed]

The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma [Recruiting]

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma [Completed]

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C [Completed]

Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma [Recruiting]

Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection [Terminated]

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis [Active, not recruiting]

A Study of Tumor Necrosis Factor and Human Interferon-Gamma in Patients With AIDS Related Complex [Completed]

The Safety and Effectiveness of Injections of Human Recombinant Interferon-Gamma in Patients With AIDS Who Have Taken Zidovudine [Completed]

Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma [Completed]

Lexatumumab With or Without Recombinant Interferon Gamma in Treating Young Patients With Solid Tumors or Lymphoma That Have Relapsed or Not Responded to Treatment [Recruiting]

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors [Completed]

Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis [Completed]

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections [Completed]

A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections [Completed]

Autologous T Cells, Low-Dose Recombinant Interferon Gamma, Cyclophosphamide, and Low-Dose Aldesleukin in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery [Not yet recruiting]

Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis [Completed]

Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients [Recruiting]

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients [Terminated]

Usefulness of Interferon-gamma Release Assay in Diagnosing Pulmonary Nodules [Recruiting]

Assessment of the Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease [Recruiting]

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs [Active, not recruiting]

Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon Gamma in Treating Patients With Advanced Colorectal Cancer [Completed]

Biological Therapy in Treating Patients With Prostate Cancer [Completed]

Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children [Recruiting]

CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) [Completed]

Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis [Completed]

Interferon-Gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma [Active, not recruiting]

Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer [Completed]

Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay [Recruiting]

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma [Active, not recruiting]

Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma [Recruiting]

A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Completed]

An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Completed]

A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Completed]

A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg) [Recruiting]

A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone [Terminated]

Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection [Not yet recruiting]

Detection of Latent Tuberculosis in Hemodialysis Patients [Completed]

A Pilot Study of Aerosol Interferon-Gamma Treatment in Pulmonary Fibrosis [Completed]

A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood [Completed]

Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-Cell Lymphoma [Recruiting]

Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis [Recruiting]

The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS [Completed]

Evaluation of Interferon-Gamma Responses to HCMV Infection in HIV Positive Individuals [Recruiting]

A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease [Completed]

Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis [Completed]

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma [Active, not recruiting]

Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis [Not yet recruiting]

Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection [Recruiting]

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis [Recruiting]

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer [Active, not recruiting]

T Cell Interferon-Gamma Release Assay (TIGRA) in Immunocompromised Individuals [Recruiting]

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [Active, not recruiting]

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer [Completed]

Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB [Recruiting]

Gamma Interferon Therapy for Chronic Hepatitis C [Completed]

Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Subjects Aged From 50 Years Old [Recruiting]

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer [Active, not recruiting]

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [Active, not recruiting]

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer [Active, not recruiting]

Tumor Cell Vaccine in Treating Patients With Advanced Cancer

A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts [Recruiting]

Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon) [Recruiting]

Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis [Recruiting]

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Recruiting]

ITV Extension Study [Completed]

Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections [Completed]

Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients [Recruiting]

Immune Response to Mycobacterium Tuberculosis Infection [Recruiting]

Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections [Recruiting]

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers. [Completed]

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults [Recruiting]

Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals [Not yet recruiting]

A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) [Recruiting]

Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata [Not yet recruiting]

Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonist [Not yet recruiting]

Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection [Recruiting]

Monoclonal Antibody Treatment of Crohn's Disease [Completed]

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3 [Completed]

Immune Responses to Mycobacterium Tuberculosis [Recruiting]

Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis [Recruiting]

Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study [Completed]

Vaccine Therapy and GM-CSF in Treating Patients With Myeloid Cancer [Recruiting]

Cytokine Gene Polymorphisms in Bone Marrow Failure [No longer recruiting]

Investigating Cytokine Genes of Stem Cell Donors [No longer recruiting]

Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Not yet recruiting]

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012